ECIM 2027 is Taking Place in Paris!

Submitted by Catalina on 9 April 2026 - 14:34

We are delighted to announce that the 25th edition of the European Congress of Internal Medicine (ECIM 2027) will take place in Paris from 31 March to 3 April 2027.

Join us at the iconic Cité des sciences et de l'industrie for an enriching and engaging scientific experience. The congress will feature a comprehensive programme including scientific sessions, keynote lectures, interactive workshops, clinical case discussions, and poster presentations.

Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Date of authorisation: 16/03/2016, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 9 April 2026 - 13:50

Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Date of authorisation: 16/03/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Withdrawn

Submitted by Anonymous (not verified) on 9 April 2026 - 13:33

Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Withdrawn

Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline

Submitted by Anonymous (not verified) on 9 April 2026 - 12:44

Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline

ECIM 2026 Featured on Medscape

Submitted by Catalina on 9 April 2026 - 11:08

We are pleased to share that ECIM 2026 has been featured in six articles published on Medscape. These articles showcase the different scientific discussions and research presented during the congress. 

The Medscape coverage reflects the relevance and impact of the presentations delivered at the ECIM 2026, helping expand their visbility to a wider audience. 

Please find the Medscape articles in the link below:

Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 9 April 2026 - 10:44

Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More